healthnotesMar 18, 2024

An amazing story from STAT's Bob Herman showing how #PBMs protect their profits even when cheaper #generics or #biosimilars reach the market.

As #Humira biosimilars take over the market, $CVS has created a new ploy: the drug ‘rebate credit’ #rebatecredit
https://www.statnews.com/2024/03/18/humira-pbms-cvs-caremark-rebate-credits/

As Humira biosimilars take over the market, CVS has created a new ploy: the drug ‘rebate credit’

As Humira biosimilars have taken over the market, CVS Caremark has created a new ploy to make money: the drug "rebate credit."

STAT